These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 15905711

  • 1. The case against using 5-aminosalicyclates in Crohn's disease: con.
    Stange EF.
    Inflamm Bowel Dis; 2005 Jun; 11(6):613-5. PubMed ID: 15905711
    [No Abstract] [Full Text] [Related]

  • 2. The case for using 5-aminosalicyclates in Crohn's disease: pro.
    Hanauer SB.
    Inflamm Bowel Dis; 2005 Jun; 11(6):609-12. PubMed ID: 15905710
    [Abstract] [Full Text] [Related]

  • 3. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
    Bauer WM, Brzezinski A, Lashner BA.
    Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
    [Abstract] [Full Text] [Related]

  • 4. Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.
    Kamm MA.
    Inflamm Bowel Dis; 2005 Jun; 11(6):616-7. PubMed ID: 15905712
    [Abstract] [Full Text] [Related]

  • 5. [Improved treatment of Crohn's disease].
    Nau JY.
    Rev Med Suisse; 2005 May 04; 1(18):1241. PubMed ID: 15977716
    [No Abstract] [Full Text] [Related]

  • 6. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
    Rutgeerts P.
    Gut; 2001 Apr 04; 48(4):452-3. PubMed ID: 11247886
    [No Abstract] [Full Text] [Related]

  • 7. 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.
    Feagan BG.
    Clin Gastroenterol Hepatol; 2004 May 04; 2(5):376-8. PubMed ID: 15118974
    [No Abstract] [Full Text] [Related]

  • 8. Mesalamine in the treatment of active Crohn's disease.
    Dignass A, Marteau P.
    Gastroenterology; 2005 Jan 04; 128(1):245-6; author reply 246. PubMed ID: 15633152
    [No Abstract] [Full Text] [Related]

  • 9. Mesalamine maintenance therapy for Crohn's disease.
    Feagan BG, McDonald JW.
    Gastroenterology; 2001 Feb 04; 120(2):585-6. PubMed ID: 11271451
    [No Abstract] [Full Text] [Related]

  • 10. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
    Feagan BG.
    Eur J Surg; 1998 Dec 04; 164(12):903-9. PubMed ID: 10029385
    [No Abstract] [Full Text] [Related]

  • 11. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE, Hanauer SB.
    Gastroenterol Clin North Am; 2004 Jun 04; 33(2):303-17, ix-x. PubMed ID: 15177540
    [Abstract] [Full Text] [Related]

  • 12. Mesalamine and relapse prevention in Crohn's disease.
    Cottone M, Cammà C.
    Gastroenterology; 2000 Aug 04; 119(2):597. PubMed ID: 10960274
    [No Abstract] [Full Text] [Related]

  • 13. Mesalazine as a maintenance treatment in Crohn's disease.
    Sutherland LR, Steinhart AH.
    Gut; 1998 Jan 04; 42(1):143-4. PubMed ID: 9505902
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.
    Akobeng AK.
    Am J Gastroenterol; 2011 Oct 04; 106(10):1857; author reply 1857-8. PubMed ID: 21979212
    [No Abstract] [Full Text] [Related]

  • 15. 5-aminosalicylates to prevent relapse of Crohn's disease after surgery.
    Doherty G, Moss AC.
    Am J Gastroenterol; 2012 Mar 04; 107(3):487; author reply 487-8. PubMed ID: 22388032
    [No Abstract] [Full Text] [Related]

  • 16. Obstructing Crohn's disease of the duodenum: is surgery always mandatory?
    Karaoglu AO, Yukselen V.
    Int J Clin Pract; 2004 Feb 04; 58(2):221-3. PubMed ID: 15055874
    [Abstract] [Full Text] [Related]

  • 17. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC, Hanauer S.
    Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008870. PubMed ID: 21154400
    [Abstract] [Full Text] [Related]

  • 18. Aminosalicylates and Elderly-onset Colonic Crohn's Disease-More Than Meets the Eye?
    Limdi JK.
    J Crohns Colitis; 2017 Aug 01; 11(8):1022. PubMed ID: 28333225
    [No Abstract] [Full Text] [Related]

  • 19. Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
    Delgado J, Delgado B, Sztarkier I, Cagnano E, Sperber AD, Fich A.
    Isr Med Assoc J; 2003 Dec 01; 5(12):897-8. PubMed ID: 14689766
    [No Abstract] [Full Text] [Related]

  • 20. Budesonide led to a greater remission rate and fewer severe adverse events than did mesalamine in Crohn's disease.
    Rutgeerts P.
    Gut; 1999 Jul 01; 45(1):13-4. PubMed ID: 10498451
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.